We serve Chemical Name:4-(4,6-Dichlorpyrimidin-2-yl)morpholin CAS:10397-13-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(4,6-Dichlorpyrimidin-2-yl)morpholin
CAS.NO:10397-13-4
Synonyms:4-(4,6-Dichloropyrimidin-2-yl)morpholine;4-(4,6-Dichloro-2-pyrimidinyl)morpholine;4,6-dichloro-2-morpholinopyrimidine;4-(4,6-Dichloro-2-pyrimidyl)morpholine;2-(4-Morpholino)-4,6-dichloropyrimidine;4-(4,6-Dichloropyrimidin-2-yl)-morpholine;4-(4,6-Dichlorpyrimidin-2-yl)morpholin;Morpholine, 4-(4,6-dichloro-2-pyrimidinyl)-;T6N DOTJ A- BT6N CNJ DG FG;2-morpholino-4,6-dichloropyrimidine;F1415-0001
Molecular Formula:C8H9Cl2N3O
Molecular Weight:234.083
HS Code:2934999090
Physical and Chemical Properties:
Melting point:139.0 to 143.0 °C
Boiling point:392.9±52.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.577
PSA:38.25000
Exact Mass:233.012268
LogP:2.15
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-(4,6-Dichloropyrimidin-2-yl)morpholine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,F1415-0001 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Morpholine, 4-(4,6-dichloro-2-pyrimidinyl)- Use and application,4-(4,6-Dichlorpyrimidin-2-yl)morpholin technical grade,usp/ep/jp grade.
Related News: Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations. 4-(4,6-Dichlorpyrimidin-2-yl)morpholin manufacturer Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug. 4-(4,6-Dichlorpyrimidin-2-yl)morpholin supplier With the onset of the DMF system for APIs, the concentration of the API industry will further increase. 4-(4,6-Dichlorpyrimidin-2-yl)morpholin vendor With the onset of the DMF system for APIs, the concentration of the API industry will further increase. 4-(4,6-Dichlorpyrimidin-2-yl)morpholin factory Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.
